Pelliciari, D. H. S., Reis, C. R. A., & Bordini, C. A. (2024). Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? - a pharmacoeconomic study. Headache Medicine, 15(3), 170–174. https://doi.org/10.48208/HeadacheMed.2024.34